Table 6 Preoperative HE4 levels and characteristics of patients with epithelial ovarian cancer
From: High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer
N | Median | Range | p-value | |
|---|---|---|---|---|
Age | ||||
≤52 years | 13 | 176.7 | 39.1–1032 | |
>52 years | 72 | 436.9 | 42.8–32250 | <0.05 |
Histology | ||||
Serous | 51 | 522.2 | 65.9–6248 | |
Non-serous | 34 | 152.5 | 39.1–32250 | <0.05 |
Stage | ||||
I | 28 | 100.7 | 39.1–32250 | |
II-IV | 57 | 568.9 | 47.4–6248 | <0.001 |
Grade | ||||
3 | 51 | 587.5 | 42.8–32250 | |
1 and2 | 34 | 152.5 | 39.1–4682 | <0.001 |
Cytoreductive Surgery | ||||
Optimal | 57 | 278.2 | 39.1–32250 | |
Suboptimal | 28 | 578.2 | 80–6348 | <0.05 |